Psychiatric findings in four female carriers of Fabry disease

Psychiatric Genetics

Volumn 14, Issue 4, 2004, Pages 199-201

  Sadek, Joseph ^a   Shellhaas, Rene ^a   Camfield, Carol S ^b   Camfield, Peter R ^b   Burley, Joe ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Anderson Fabry disease; Depression; Female carriers; Nova Scotia

Indexed keywords

ALPHA GALACTOSIDASE; GLYCOSPHINGOLIPID;

ADULT; AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; EMPLOYMENT; FABRY DISEASE; FATIGUE; FEMALE; GUILT; HAMILTON SCALE; HETEROZYGOTE; HUMAN; MAJOR DEPRESSION; PRIORITY JOURNAL; QUALITY OF LIFE; SUICIDAL BEHAVIOR; X CHROMOSOME RECESSIVE DISORDER;

ADULT; AGED; CHROMOSOMES, HUMAN, X; FABRY DISEASE; FATIGUE; FEMALE; GUILT; HETEROZYGOTE DETECTION; HUMANS; MIDDLE AGED;

EID: 11144239006     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041444-200412000-00006     Document Type: Article

References (12)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV, 4th edition. Washington, DC: American Psychiatric Association.
2. Brady RO, Schiffmann R (2000). Clinical features of and recent advances in therapy for Fabry disease. J Am Med Assoc 284:2771-2775.
3. Germain DP (2000). Fabry disease. Clinical and genetic aspects. Therapeutic perspectives. Rev Med Interne 21:1086-1103.
4. Grewal RP (1993). Psychiatric disorders in patients with Fabry's diseaes. Int J Psychiatry Med 23:307-312.
5. Hirano K, Murata K, Miyagawa A, Terasaki H, Saigusa J, Nagasaka T, Kobayashi M (2001). Histopathologic findings of cornea verticillata in a woman heterozygous for Fabry's disease. Cornea 20:233-236.
6. Hopman WH, Towheed T, Anastassiades T, Tenenhouse A, Poliquin S, Berger C, et al., and The Canadian Multicentre Osteoporosis Study Research Group (2000). Canadian normative data for the SF-36 health survey. Canadian Medical Association Journal (CMAJ) 163:265-271.
7. Kirkilionis AJ, Riddell DC, Spence MW, Fenwick RG (1991). Fabry disease in a large Nova Scotia kindred: carrier detection using leucocyte alpha-galactosidase activity and an Ncol polymorphism detected by an alpha-galactosidase cDNA clone. J Med Genet 28:232-240.
8. Linthorst GE, Hollak CE, Bosman DK, Heymans HS, Aerts JM (2000). Fabry's disease; towards a treatment. Ned Tijdschr Geneeskd 144:2391-2395.
9. MacDermot KD, Holmes A, Miners AH (2001). Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769-775.
10. Morgan SH, Rudge P, Smith SJ, Bronstein AM, Kendall BE, Holly E, et al. (1990). The neurological complications of Anderson-Fabry disease (alpha-galactosidase A deficiency) - investigation of symptomatic and presymptomatic patients. Q J Med 75:491-507.
11. Williams JB (2001). Standardizing the Hamilton Depression Rating Scale: past, present, and future. Eur Arch Psychiatry Clin Neurosci 251 (suppl 2):116-1112.
12. Yoshitama T, Nakao S, Takenaka T, Teraguchi H, Sasaki T, Kodama C, et al. (2001). Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease. Am J Cardiol 87:71-75.